Trials / Conditions / Idiopathic Thrombocytopenic Purpura (ITP)

Idiopathic Thrombocytopenic Purpura (ITP)

7 registered clinical trials studyying Idiopathic Thrombocytopenic Purpura (ITP) — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thro NCT07194850	argenx	Phase 2 / Phase 3
Completed	Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Ver NCT01437384	Eisai Inc.	Phase 1
Completed	Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients NCT00860600	PhytoHealth Corporation	Phase 2
Terminated	Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP NCT00571467	Protalex, Inc.	Phase 1
Completed	Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients NCT00362349	CSL Limited	Phase 3
Withdrawn	A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone NCT00161564	Weill Medical College of Cornell University	Phase 2
Completed	Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) NCT01713738	Neufeld, Ellis J, MD, PhD	Phase 1 / Phase 2